Thesis (doctoral)--Ludwig Maximilians-Universität zu München, 1979.

No description available.

Thesis (doctoral)--Universitetet i Lund.

The aortic valve (AV) functions in arguably the most demanding mechanical environment in the body. The AV experiences fluid shear stress, cyclic pressure and mechanical strain in vivo. Recent evidence has shown the progression of degenerative aortic valve disease (AVD) to be an active cellular mediated process, altering the conception of the AV as a passive tissue. AVD has shown a strong correlation with altered hemodynamics and tissue mechanics. Aortic valve endothelial cells (AVECs) line the fibrosa (aortic facing) and ventricularis (left ventricle facing) surfaces of the valve. AVECs sense and respond to circulating stimuli in the blood stream while maintaining a non-thrombogenic layer. AVEC activation has been implicated in the initiation and progression of AVD, but the role of cyclic strain has yet to be elucidated. The hypothesis of this dissertation is that altered mechanical forces have a causal relationship with aortic valvular endothelial cell activation. To test this hypothesis 1) the role of in vitro cyclic strain in regulating expression of pro-inflammatory adhesion molecule was elucidated 2) cyclic strain-dependent activation of side-specific aortic valve endothelial cells was investigated 3) a novel stretch bioreactor was developed to dramatically increase the ability to correlate valvular endothelium response to physiologically relevant applied planar biaxial loads. The results from this study further the field of heart valve mechanobiology by correlating AVEC physiological and pathophysiological function to cellular and tissue level strain. Elucidating the AVEC response to an altered mechanical environment may result in novel clinical diagnostic and therapeutic approaches to the initiation and progression of degenerative AVD. Furthermore, a cardiovascular health outreach program, Bulldogs for Heart Health, has been designed and implemented to combat the startling rise in childhood obesity in the state of Mississippi. It is the hope that these results, novel methods, and outreach initiatives developed will significantly impact the study of the mechanobiology of the aortic valve endothelial cell and potential treatment and prevention of cardiovascular disease.

The gold standard treatment for patients with AVD is surgical replacement of the aortic valve with either mechanical or fixed tissue prostheses. These implants have a limited lifespan and are associated with serious adverse events. Patient autologous tissue engineered heart valves (TEHVs) offer a solution. Vital to the development of a TEHV is determining a source of donor tissue(s) that most closely mimics the native valve tissue. In pursuit of determining an alternative cell source for patient autologous TEHVs we compared a number of phenotypic and genotypic characteristics of atrial fibroblasts, dermal fibroblasts and differentiated bone marrow-derived progenitor cells (BMCs) and made a comparison to valvular interstitial cells (VICS). We demonstrate that while VICs share some phenotypic similarities with fibroblasts and BMCs, they also possess unique characteristics and demonstrate differential mRNA expression of key regulatory pathways that may influence their phenotype. / October 2016

The optimal timing of valve replacement surgery in chronic severe aortic regurgitation (AR) has remained a major clinical problem in the management of these patients. Although the onset of symptoms is the generally accepted indication for aortic valve replacement (AVR), the unpredictable development of pre-symptomatic left ventricular (LV) dysfunction as a result of prolonged volume overload has resulted in numerous reports attempting to formulate a risk profile for these patients. Although aortic root and LV cineangiography have been the "gold standard" for defining the severity of AR and its effect on LV performance, serial follow-up by these means is impractical. More recently numerous non-invasive measures of LV size (echocardiogram) and function both at rest and on exercise (echocardiogram and equilibrium radionuclide angiocardiography., ERNA) have been serially utilised~ In these endeavours, the thinking has been clouded by a tendency to equate these two measures and failing to appreciate that apparent preoperative LV dysfunction (particularly on exercise) may be rapidly reversible by AVR and the consequent changes in LV loading conditions. This study was a prospective, sequential evaluation of left ventricular function using both non-invasive and invasive techniques in symptomatic and asymptomatic patients with isolated chronic, severe (4+) AR at cardiac catheterisation. The aims of the study were to (I) Identify differences in the clinical, echocardiographic, resting and exercise haemodynamic and I radionuclide measures of left ventricular function in symptomatic and asymptomatic patients with chronic severe A.R. with particular reference to the incidence of presymptomatic development of left ventricular dysfunction. (II) Critically evaluate the role of exercise stress (both isotonic and isometric) in the assessment of patients with chronic severe A.R. (III) Evaluate the influence of time (sequential studies) on the haemodynamic burden in asymptomatic patients. (IV) Study the impact of successful aortic valve replacement on the reversibility of abnormal pre-operative LV function in an attempt to predict which patients would benefit from this therapeutic intervention and whether operation for symptoms alone is the correct clinical practice.

Thesis (doctoral)--Ludwig Maximilians-Universität zu München, 1979.

Thesis (MScEng)--University of Stellenbosch, 2008. / Bibliography. Also available via the Internet.

In calcific aortic valve disease, the early sclerotic valve lesion is similar to the atherosclerotic arterial plaque, but at the later stage calcification prevails. Our aim was to assess the association of several new potential risk factors, eg. systemic inflammation, neurohormonal activation and altered calcium metabolism with aortic stenosis (AS) in patients with significant coronary artery disease..

La bicuspidie aortique représente la malformation cardiaque congénitale la plus fréquente, affectant environ 2% de la population. Paradoxalement, le mécanisme de dégénérescence accélérée d’une valve bicuspide n’est pas encore élucidé. Ce travail s’appuie sur l’analyse de modèles animaux et sur l’analyse d’une cohorte prospective de 300 patients porteurs d’une valve aortique bicuspide.Notre cohorte de 300 patients nous a permis de chercher à identifier de nouveaux gènes impliqués dans la bicuspidie aortique par des approches de séquençage nouvelle génération, mais aussi par une approche de gène candidat. La comparaison des données cliniques et échographiques des patients porteurs de bicuspidie aortique avec et sans dysfonctionnement nous a permis d’établir une corrélation entre le phénotype de la bicuspidie et fonction valvulaire.Ce travail a eu pour objectif d’améliorer la compréhension de la physiopathologie de la bicuspidie aortique en identifiant de nouveaux gènes candidats et d’acquérir une meilleure connaissance du processus de dégénérescence valvulaire accélérée par le biais de modèles murins et d’études cliniques. / Bicuspid Aortic Valve (BAV) is the most common congenital heart defect, affecting about 2% of the population. BAV is a heritable trait, but the genetic basis underlying this defect remains unclear. BAV is associated with an excess of morbidity and mortality related to several complications such as accelerated valve degeneration that required earlier and more frequent referral for surgery. Despite its burden, the mechanism underlying BAV degeneration has not been elucidated. Aortic valve replacement constitutes a late response to a disease whose diagnosis is often carried out earlier, at the stage of non-severity. My thesis aims to identify the pathophysiology of BAV and to investigate the mechanisms involved in BAV degeneration. Thus, this study was based on the analysis of animal models and on the examination of a prospective cohort of 300 patients with BAV. Three hundred patients with BAV were prospectively included in our cohort to identify new genes involved in BAV by next generation sequencing and candidate-gene approach. The objective of this thesis was to improve our understanding of the pathophysiology of BAV and to assess the mechanisms underlying BAV degeneration by analyzing animal and clinical models.